<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>adr.org.uk &#187; Our research</title>
	<atom:link href="http://adr.org.uk/category/our-research/feed/" rel="self" type="application/rss+xml" />
	<link>http://adr.org.uk</link>
	<description>West Midlands Centre for Adverse Drug Reactions</description>
	<lastBuildDate>Wed, 12 May 2010 13:59:36 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Angioedema and angiotensin-II receptor blockers</title>
		<link>http://adr.org.uk/2009/10/angioedema-and-angiotensin-ii-receptor-blockers/</link>
		<comments>http://adr.org.uk/2009/10/angioedema-and-angiotensin-ii-receptor-blockers/#comments</comments>
		<pubDate>Tue, 06 Oct 2009 10:11:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ADRs]]></category>
		<category><![CDATA[Our research]]></category>

		<guid isPermaLink="false">http://adr.org.uk/?p=243</guid>
		<description><![CDATA[Angioedema is a rare serious adverse drug reaction (ADR) to angiotensin-converting enzyme inhibitors (ACE-I), with an incidence of 0.1% to 1.0%. If untreated it can be life-threatening. Debate exists over the safety of switching to an angiotensin-II receptor blocker (ARB), due to case reports of angioedema, and the mechanism of ARB-associated angioedema. The DoTS system [...]]]></description>
			<content:encoded><![CDATA[<p>Angioedema is a rare serious adverse drug reaction (ADR) to angiotensin-converting enzyme inhibitors (ACE-I), with an incidence of 0.1% to 1.0%. If untreated it can be life-threatening. Debate exists over the safety of switching to an angiotensin-II receptor blocker (ARB), due to case reports of angioedema, and the mechanism of ARB-associated angioedema. The <a href="http://www.bmj.com/cgi/content/extract/327/7425/1222">DoTS system of ADR classification </a>provides a structured template for examining the <strong>Do</strong>se and <strong>T</strong>ime relationship, and potential <strong>S</strong>usceptabilities to an ADR.</p>
<p>Here is a poster we are presenting at the International Society of Pharmacovigilance conference this week.</p>
<p><a href="http://www.blacktriangle.org/angioedemaISOP2009.pdf">Angioedema associated with angiotensin-II receptor blockers: a DoTS classification<br />
and analysis</a> [PDF].</p>
]]></content:encoded>
			<wfw:commentRss>http://adr.org.uk/2009/10/angioedema-and-angiotensin-ii-receptor-blockers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Recent Research Findings</title>
		<link>http://adr.org.uk/2007/12/recent-research-findings/</link>
		<comments>http://adr.org.uk/2007/12/recent-research-findings/#comments</comments>
		<pubDate>Tue, 11 Dec 2007 13:56:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Our research]]></category>

		<guid isPermaLink="false">http://adr.org.uk/?p=137</guid>
		<description><![CDATA[The following are three posters this unit recently presented at ISOP 2007 in October of this year:
Cox AR, Anton C, Marriott JF, Ferner RE. The paradox of low prescribers who are high reporters: correlates of spontaneous reporting of adverse drug reactions within primary care. Drug Safety 2006; 30(10): 977-978
(Presented at the 7th Annual Meeting of [...]]]></description>
			<content:encoded><![CDATA[<p>The following are three posters this unit recently presented at <a href="http://www.isop2007.org/">ISOP 2007</a> in October of this year:</p>
<p>Cox AR, Anton C, Marriott JF, Ferner RE. The paradox of low prescribers who are high reporters: correlates of spontaneous reporting of adverse drug reactions within primary care. <em>Drug Safety</em> 2006; <strong>30(10)</strong>: 977-978<br />
(Presented at the 7th Annual Meeting of ISoP Bournemouth &#8211; UK, 21-24 October 2009)</p>
<p><a href="http://www.adr.org.uk/pdf/GPsISOP2007.pdf">Download PDF of Poster</a></p>
<p>McDowell SE, Coleman JJ, Ferner RE. Rhabdomyolysis and statins &#8211; an analysis of spontaneous case reports using a three-diensional classification scheme. <em>Drug Safety</em> 2006; <strong>30(10)</strong>: 979<br />
(Presented at the 7th Annual Meeting of ISoP Bournemouth &#8211; UK, 21-24 October 2009)</p>
<p><a href="http://www.adr.org.uk/pdf/StatinsISOP2007.pdf">Download PDF of Poster</a></p>
<p>Ormerod S, McDowell SE, Coleman JJ, Ferner RE. Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses: systematic review and meta-analysis. <em>Drug Safety</em> 2006; <strong>30(10)</strong>: 975-976<br />
(Presented at the 7th Annual Meeting of ISoP Bournemouth &#8211; UK, 21-24 October 2009)</p>
<p><a href="http://www.adr.org.uk/pdf/ethnosISOP2007.pdf">Download PDF of Poster</a></p>
]]></content:encoded>
			<wfw:commentRss>http://adr.org.uk/2007/12/recent-research-findings/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ISOP 2006</title>
		<link>http://adr.org.uk/2006/10/isop-2006/</link>
		<comments>http://adr.org.uk/2006/10/isop-2006/#comments</comments>
		<pubDate>Fri, 20 Oct 2006 08:42:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Our research]]></category>

		<guid isPermaLink="false">http://adr.org.uk/drugsafety/?p=68</guid>
		<description><![CDATA[The Yellow Card Centre West Midlands staff attended the 6th annual conference of the International Society of Pharmacovigilance in Liege, Belgium. We displayed three research posters and delivered an oral presentation on a variety of subjects related to drug safety.

Download Presentation

Download poster

Download poster

Download poster
]]></description>
			<content:encoded><![CDATA[<p>The Yellow Card Centre West Midlands staff attended the <em>6th annual conference of the International Society of Pharmacovigilance</em> in Liege, Belgium. We displayed three research posters and delivered an oral presentation on a variety of subjects related to drug safety.</p>
<p><center><img id="image64" alt=antonisop2006.jpg src="http://adr.org.uk/drugsafety/wp-content/uploads/2006/10/antonisop2006.jpg" /></center></p>
<p><center><a id=p72 href="http://adr.org.uk/drugsafety/wp-content/uploads/2006/10/targetedfollowupisop2006.pdf">Download Presentation</a></center></p>
<p><center><img id="image65" alt=colemanmcdowellisop2006.jpg src="http://adr.org.uk/drugsafety/wp-content/uploads/2006/10/colemanmcdowellisop2006.jpg" /></center></p>
<p><center><a id=p71 href="http://adr.org.uk/drugsafety/wp-content/uploads/2006/10/manslaughterisop260906.pdf">Download poster</a></center></p>
<p><center><img id="image67" alt=coxisop2006.jpg src="http://adr.org.uk/drugsafety/wp-content/uploads/2006/10/coxisop2006.jpg" /></center></p>
<p><center><a id=p69 href="http://adr.org.uk/drugsafety/wp-content/uploads/2006/10/gpattitudesisopleige2006.pdf">Download poster</a></center></p>
<p><center><img id="image66" alt=coxcoleantonisop2006.jpg src="http://adr.org.uk/drugsafety/wp-content/uploads/2006/10/coxcoleantonisop2006.jpg" /></center></p>
<p><center><a id=p70 href="http://adr.org.uk/drugsafety/wp-content/uploads/2006/10/websitereviewisop2006.pdf">Download poster</a></center></p>
]]></content:encoded>
			<wfw:commentRss>http://adr.org.uk/2006/10/isop-2006/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chief Pharmacists&#8217; views of Adverse Drug Reaction Reporting.</title>
		<link>http://adr.org.uk/2004/11/chief-pharmacists-views-of-adverse-drug-reaction-reporting/</link>
		<comments>http://adr.org.uk/2004/11/chief-pharmacists-views-of-adverse-drug-reaction-reporting/#comments</comments>
		<pubDate>Wed, 03 Nov 2004 13:08:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Our research]]></category>
		<category><![CDATA[Yellow Card Scheme]]></category>

		<guid isPermaLink="false">http://adr.org.uk/drugsafety/?p=28</guid>
		<description><![CDATA[You can now download a PDF version of our poster presented at the International Society of Pharmacovigilance (ISOP) Annual Meeting in Dublin: Message from the top: Chief Pharmacists&#8217; views of Adverse Drug Reaction Reporting.

Anthony Cox presents the poster at the 2004 ISOP meeting in Dublin.
]]></description>
			<content:encoded><![CDATA[<p>You can now download a PDF version of our poster presented at the International Society of Pharmacovigilance (ISOP) Annual Meeting in Dublin: <a href="http://www.blacktriangle.org/blog/images/messagefromthetopisop.pdf">Message from the top: Chief Pharmacists&#8217; views of Adverse Drug Reaction Reporting.</a></p>
<p><img alt="Anthony Cox next to the poster in Dublin" src="http://www.adr.org.uk/images/acox.jpg" border="0" /></p>
<p>Anthony Cox presents the poster at the 2004 ISOP meeting in Dublin.</p>
]]></content:encoded>
			<wfw:commentRss>http://adr.org.uk/2004/11/chief-pharmacists-views-of-adverse-drug-reaction-reporting/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
